SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-197925
Filing Date
2011-07-27
Accepted
2011-07-27 06:17:00
Documents
3
Period of Report
2011-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18405
2 PRESS RELEASE DATED JULY 26, 2011 dex991.htm EX-99.1 11124
3 GRAPHIC g213042g37w98.gif GRAPHIC 1012
  Complete submission text file 0001193125-11-197925.txt   32245
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 11988699
SIC: 2834 Pharmaceutical Preparations